Halia Therapeutics Continued Support to Utah’s Industry Community Recognized by First Place at the Utah Business Innovation Awards

– Company announces the appointment of Dr. David Bearss, CEO of Halia Therapeutics, as a member of the Board of Directors at BioUtah LEHI, Utah, Oct. 31, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad…

Click here to view original post